Fri,28Nov2014

Disease

Working Group 2: Gasotransmitters in disease

Working Group Leader: Matt Whiteman (Exeter, UK)

  • Ahmed, Asif (Birmingham, UK)
  • Baxter, Gary (Cardiff, UK)
  • Beck, Charlie (Frankfurt, Germany) 
  • Behrends, Soenke ( Braunschweig, Germany)
  • Dallas, Mark (Reading, UK)
  • Djurić, Dragan (Belgrade, Serbia)
  • Dulak, Jozef (Krakow, Poland)
  • Feelisch, Martin (Southampton, UK)
  • Ferdinandy, Peter (Szeged, Hungary)
  • Levente, Kiss (Budapest, Hungary)
  • Levy, Finn Olav (Oslo, Norway)
  • Mancardi, Daniele (Turin, Italy)
  • Otasevic, Vesna (Belgrade, Serbia)
  • Pechanova, Olga (Bratislava, Slovakia)
  • Pfeilschifter Josef (Frankfurt, Germany)
  • Sanchez-Ferrer, Carlos-Felix (Madrid, Spain)
  • Schinzel, Reinhard (Würzburg, Germany)
  • Schmidt, Harald (Maastricht, Netherlands)
  • Vieira, Helena (Oeiras, Portugal)
  • Wingler, Kirstin (Maastricht, Netherlands)
  • Winyard, Paul (Exeter, UK)
  • Ytrehus, Kirsti (Tromsø, Norway)

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.